NCT07354867

Brief Summary

This study aims to compare the outcomes of Simplified Robot (FASTER) assisted Endoscopic Submucosal Dissection (ESD) with conventional ESD in the treatment of colorectal lesions. Using a prospective, single-center, randomized controlled design, the investigators will systematically evaluate differences between the two approaches in terms of total procedure time, mucosal dissection time and speed, resection quality (R0 resection rate and en bloc resection rate), incidence of complications (bleeding, perforation, muscularis injury), and the flexibility and clinical feasibility of robotic operation. The clinical significance of this study lies in assessing the value of robotic assistance in colorectal ESD, optimizing intraoperative workflow, reducing complication risks, improving patient outcomes and procedural efficiency, and providing evidence to support individualized therapeutic strategies in clinical practice.This study aims to compare the outcomes of Simplified Robot (FASTER) assisted Endoscopic Submucosal Dissection (ESD) with conventional ESD in the treatment of colorectal lesions. Using a prospective, single-center, randomized controlled design, the investigators will systematically evaluate differences between the two approaches in terms of total procedure time, mucosal dissection time and speed, resection quality (R0 resection rate and en bloc resection rate), incidence of complications (bleeding, perforation, muscularis injury), and the flexibility and clinical feasibility of robotic operation. The clinical significance of this study lies in assessing the value of robotic assistance in colorectal ESD, optimizing intraoperative workflow, reducing complication risks, improving patient outcomes and procedural efficiency, and providing evidence to support individualized therapeutic strategies in clinical practice.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Jan 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress37%
Jan 2026Nov 2026

First Submitted

Initial submission to the registry

January 4, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

January 6, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 21, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

January 21, 2026

Status Verified

October 1, 2025

Enrollment Period

7 months

First QC Date

January 4, 2026

Last Update Submit

January 12, 2026

Conditions

Keywords

Endoscopic Submucosal Dissection (ESD)Colorectal lesionsFASTER robotProcedure timeRandomized controlled trial (RCT)

Outcome Measures

Primary Outcomes (1)

  • Total procedure time

    Measured from initiation of submucosal injection to completion of submucosal dissection.

    Recorded intraoperatively

Secondary Outcomes (7)

  • En bloc resection rate

    Periprocedural (intraoperative assessment)

  • Submucosal dissection time

    Recorded intraoperatively

  • Robotic operational flexibility

    Recorded intraoperatively

  • Dissection speed

    Periprocedural (from intraoperative measurement to postoperative calculation within 24 hours)

  • Incidence of device malfunction

    Recorded intraoperatively

  • +2 more secondary outcomes

Study Arms (2)

FASTER robot-assisted ESD group

EXPERIMENTAL

FASTER robot-assisted ESD group - Patients undergo ESD with the FASTER robotic arm attached to the endoscope tip, with robotic grasping to assist submucosal dissection.

Other: FASTER robot-assisted ESD group

Conventional colorectal ESD

ACTIVE COMPARATOR

Conventional colorectal ESD - Patients undergo standard ESD using a transparent distal cap without robotic assistance.

Other: Conventional ESD group

Interventions

In the experimental group, the FASTER robotic arm will be attached to the tip of the endoscope at the beginning of the procedure. ESD will then be performed according to the standard steps of conventional ESD: (1) lesion marking; (2) submucosal injection with normal saline mixed with indigo carmine; and (3) circumferential incision. After completion of the submucosal injection and circumferential incision, the robotic arm will be deployed, and the end-effector grasper will grasp and lift the mucosal edge to provide a clear view of the dissection plane, after which submucosal dissection will be performed. Finally, the resected specimen will be retrieved using the FASTER system through the endoscope or via suction. Throughout the procedure, patients' vital signs and any procedure-related serious adverse events will be recorded for statistical analysis

FASTER robot-assisted ESD group

In the control group, a transparent distal attachment cap will be mounted onto the tip of the endoscope at the beginning of the procedure. ESD will then be performed following the standard steps of conventional ESD, including: (1) lesion marking; (2) submucosal injection using normal saline mixed with indigo carmine; (3) circumferential incision; (4) submucosal dissection; and (5) retrieval of the resected specimen via suction. Throughout the procedure, patients' vital signs and any procedure-related serious adverse events will be recorded for statistical analysis.

Conventional colorectal ESD

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 80 years.
  • Patients with colorectal lesions scheduled to undergo endoscopic submucosal dissection (ESD)
  • Lesion characteristics meeting any of the following criteria: (1) Lesions unsuitable for en bloc resection using snare-based EMR, including non-granular type laterally spreading tumors (LST-NG), especially pseudo-depressed subtype (PD); lesions with type VI pit pattern (VI-type glandular opening configuration); carcinomas with superficial submucosal invasion (T1-SM); large depressed-type tumors; large protruding lesions suspected of malignancy, including nodular mixed-type granular LSTs (LST-G); other lesions unsuitable for en bloc resection using snare-based EMR; (2) Lesions with special background conditions, including mucosal tumors with submucosal fibrosis (caused by prior biopsy or mucosal prolapse due to peristalsis); sporadic tumors arising in the context of chronic inflammation (e.g., ulcerative colitis); local residual or recurrent early carcinoma following prior endoscopic resection;
  • Willingness to participate in the study and provision of written informed consent.

You may not qualify if:

  • Suspected deep submucosal invasive carcinoma based on endoscopic features;
  • Lesions presenting with non-lifting signs, suggesting deep submucosal invasive carcinoma or tumors with severe submucosal fibrosis;
  • Lesions extending to the appendiceal orifice, colonic diverticulum, or ileocecal valve; (4) Pregnant women or women who may be pregnant; lactating women;
  • Pregnant women or women who may be pregnant; lactating women;
  • Patients with coagulation disorders;
  • Patients considered ineligible for specific reasons;
  • Patients with contraindications to anesthesia and/or colonoscopy. -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

xiaobing cui

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
This is a single-blind study in which the outcomes assessor is blinded to group allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned in a 1:1 ratio to one of two parallel groups: a FASTER robot-assisted ESD group or a conventional ESD group. Both groups will undergo the assigned endoscopic submucosal dissection procedure for colorectal lesions performed by experienced endoscopists. In the robot-assisted group, the FASTER robotic arm will provide multidirectional traction using its end-effector grasper to optimize the submucosal field during dissection, whereas the control group will complete submucosal dissection using standard ESD techniques. Outcomes will be compared between groups to evaluate differences in procedure time, mucosal dissection time and speed, resection quality, complication rates, procedural stability, and robotic maneuverability.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator, Clinical Professor

Study Record Dates

First Submitted

January 4, 2026

First Posted

January 21, 2026

Study Start

January 6, 2026

Primary Completion (Estimated)

July 30, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

January 21, 2026

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share